(1)
Ismail, H.; Alzubaidi, F. A.; Oubaid, E. N. Targeting the IL-33 ST2 Signalling Pathway As a Therapeutic Strategy for the Treatment of Multiple Inflammatory Diseases. P 2025, 37.